MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...

Egg-based antibody demonstrated significant improvements in poultry livability and feed efficiency across commercial broiler, ...

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

Immutep shares update on Phase I study of LAG-3 agonist antibody for autoimmune diseases, showing positive safety & efficacy ...

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a ...

Common genetic variants can prevent antibody therapies from binding their targets, reducing treatment effectiveness. The ...

Overall, 71.8% (61.5% confirmed) of patients had partial responses to either of two dose levels of pumitamig plus ...

The MarketWatch News Department was not involved in the creation of this content.-- Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, l ...

Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based antibody designer says will help it accelerate its research and product development, as well ...

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against ...